Cardiff Oncology saw its shares nosedive following the departure of its CEO and CFO, plus questions about some Phase II data for its candidate onvansertib in first-line RAS-mutated metastatic ...
Prior seasonal influenza virus immunity did not impair antibody responses or protection conferred by the intranasal H5N1 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results